HLA-DQB1

Chr 6ARMultiAD

major histocompatibility complex, class II, DQ beta 1

Also known as: CELIAC1, HLA-DQB, IDDM1

HLA-DQB1 belongs to the HLA class II beta chain paralogs. This class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and it contains six exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]

Primary Disease Associations & Inheritance

{Celiac disease, susceptibility to}MIM #212750
ARMulti
{Creutzfeldt-Jakob disease, variant, resistance to}MIM #123400
AD
{Multiple sclerosis, susceptibility to, 1}MIM #126200
Multi
20
ClinVar variants
6
Pathogenic / LP
0.01
pLI score
0
Active trials
Clinical SummaryHLA-DQB1
Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
6 Pathogenic / Likely Pathogenic· 4 VUS of 20 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.94LOEUF
pLI 0.009
Z-score 1.70
OE 0.45 (0.230.94)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.31Z-score
OE missense 0.68 (0.570.81)
91 obs / 133.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.45 (0.230.94)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.68 (0.570.81)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.60
01.21.6
LoF obs/exp: 5 / 11.1Missense obs/exp: 91 / 133.7Syn Z: 2.25

ClinVar Variant Classifications

20 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic2
VUS4
Likely Benign8
Benign2
4
Pathogenic
2
Likely Pathogenic
4
VUS
8
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
4
0
4
Likely Pathogenic
1
0
1
0
2
VUS
0
0
4
0
4
Likely Benign
0
2
1
5
8
Benign
1
0
1
0
2
Total2211520

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

HLA-DQB1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

{Celiac disease, susceptibility to}

MIM #212750

Molecular basis of disorder known

Autosomal recessiveMultifactorial

{Creutzfeldt-Jakob disease, variant, resistance to}

MIM #123400

Molecular basis of disorder known

Autosomal dominant

{Multiple sclerosis, susceptibility to, 1}

MIM #126200

Molecular basis of disorder known

Multifactorial
📖
GeneReview available — HLA-DQB1
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
The HLA complex and coeliac disease.
Espino L et al.·Int Rev Cell Mol Biol
2021Review
The immunopathogenesis of narcolepsy type 1.
Liblau RS et al.·Nat Rev Immunol
2024Review
[Narcolepsy with cataplexy].
Dauvilliers Y et al.·Rev Neurol (Paris)
2008Review
Pharmacogenetics-Guided Advances in Antipsychotic Treatment.
Islam F et al.·Clin Pharmacol Ther
2021Review
Narcolepsy and immunity.
Mignot E et al.·Adv Neuroimmunol
1995Review
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →